Clinical Trials Directory

Trials / Completed

CompletedNCT03700346

Muscle Lactate and Lactate to Pyruvate Ratio Clearance in Septic Shock Patients

Muscle Lactate and Lactate to Pyruvate Ratio Clearance as Useful Biomarkers for the Prediction of Mortality in Septic Shock Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Military Hospital of Tunis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We conducted this study aiming to assess the performance of muscle Lactate and lactate to pyruvate (L/P) ratio clearance in predicting mortality in septic shock patients by using microdialysis.

Detailed description

Microcirculatory alterations are frequently observed in patients with sepsis. In vivo microdialysis (MD) is a bedside technique that can monitor tissue metabolic changes. We conducted this study aiming to assess the performance of muscle Lactate and lactate to pyruvate (L/P) ratio clearance in predicting mortality in septic shock patients by using microdialysis. Interstitial tissue concentrations of lactate, pyruvate, glucose and glycerol were obtained at baseline and every 6 hours for 3 days by using muscle microdialysis. Clearances of muscle lactate, and L/P ratio were defined as the percentage change in muscle lactate level or L/P ratio compared to baseline (H0) values. A positive value of clearance means a decrease in the rate of the parameter under study.

Conditions

Interventions

TypeNameDescription
DEVICEmicrodialysisInterstitial tissue concentrations of lactate, pyruvate, glucose and glycerol were obtained by using muscle microdialysis

Timeline

Start date
2018-01-01
Primary completion
2018-10-30
Completion
2018-12-31
First posted
2018-10-09
Last updated
2021-04-20

Locations

2 sites across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT03700346. Inclusion in this directory is not an endorsement.